← Companies|CervoMed
CR

CervoMed

CRVO·NASDAQBothell WAFounded 201940 employees
Small CapbiotechPublicNeurology
Platform: p38a Neuro
Market Cap
$0.3B
All Drugs
2
Clinical Trials
3
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (CRVO)
Loading CRVO stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
CRV-1020CRV-1020Approved1ADCCDK4/6USP1iPSPADPKD
ElrazanubrutinibCRV-763NDA/BLA2Gene TherapyPLK4GLP-1agPAH
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)
2026-02-07
Elrazanubrutinib Ph3 Readout
PAH
Past
2028-07-13
Elrazanubrutinib Ph3 Readout
PAH
Ph3 Readout